Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

With advances in molecular biologic and genomic technology, detailed molecular mechanisms for development of castration-resistant prostate cancer (CRPC) have surfaced. Metastatic prostate cancer (PCa) no longer represents an end stage, with many emerging therapeutic agents approved as effective in p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomedicine (Taipei)
Autors principals: Liu, Hsin-Ho, Tsai, Yuh-Shyan, Lai, Chen-Li, Tang, Chih-Hsin, Lai, Chih-Ho, Wu, Hsi-Chin, Hsieh, Jer-Tsong, Yang, Che-Rei
Format: Artigo
Idioma:Inglês
Publicat: China Medical University 2014
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4264971/
https://ncbi.nlm.nih.gov/pubmed/25520915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7603/s40681-014-0002-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars